Prostate Cancer | Specialty

Prostate Cancer Screening and Surveillance Continue to Evolve

March 30th 2018

William K. Kelly, DO, discusses the evolving imaging techniques and emerging therapeutic approaches in prostate cancer.

Expert Discusses Bone-Targeting Agents in Prostate Cancer

March 29th 2018

Robert B. Den, MD, discusses bone-targeting agents in prostate cancer and the potential future of combinations.

Dr. Trabulsi on Clinical Trial Combination Approaches in Prostate Cancer

March 28th 2018

Edouard J. Trabulsi, MD, FACS, professor, co-director, Multidisciplinary Genitourinary Oncology Center, Prostate Diagnostic Center, vice chair of research, director, Division of Urologic Oncology, Department of Urology, Sidney Kimmel Cancer Center, discusses clinical trials that are investigating combination approaches for patients with prostate cancer.

Genetic Testing Helps Guide Treatment in Prostate Cancer

March 28th 2018

Veda Giri, MD, discusses the developing role of genetic testing for the screening and management of patients with prostate cancer.

Gomella Gives Predictions for Prostate Cancer Advances in 2018

March 25th 2018

Leonard G. Gomella, MD, shares his insight on this year's expected advances in the field of prostate cancer.

Dr. Hussain on the Importance of Next-Generation Sequencing in Prostate Cancer

March 24th 2018

Maha Hussain, MD, FACP, FASCO, Genevieve Teuton Progessor of Medicine, Deputy Director, Robert H. Lurie Comprehensive Cncer Center, Northwestern University Feinberg School of Medicine, discusses the importance of next-generation sequencing in prostate cancer.

Dr. Mann on Differences Between Treatments for Prostate Cancer

March 23rd 2018

Mark J. Mann, MD, assistant professor, Sidney Kimmel Cancer Center, Thomas Jefferson Hospital, discusses the differences between treatment options for patients with prostate cancer subtypes.

Frontline Advances Continue in Castration-Sensitive Prostate Cancer

March 23rd 2018

James Luke Godwin, MD, recaps recent advancements in frontline metastatic castration-sensitive prostate cancer and highlights emerging agents with potential in this space.

Dr. Giri Discusses Testing for Inherited Prostate Cancer

March 23rd 2018

Veda Giri, MD, associate professor, Thomas Jefferson University Hospital, discusses testing for inherited prostate cancer.

Dr. Gomella on Screening in Prostate Cancer

March 22nd 2018

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, encourages early screening for prostate cancer.

Dr. Den Discusses Bone-Targeting Agents in Prostate Cancer

March 20th 2018

Robert B. Den, MD, associate professor of radiation oncology, Thomas Jefferson University Hospital, discusses bone-targeting agents in prostate cancer.

FDA Grants Enzalutamide Priority Review for Nonmetastatic CRPC

March 20th 2018

The FDA has granted a priority review to a supplemental new drug application (sNDA) for enzalutamide (Xtandi) for the treatment of men with nonmetastatic castration-resistant prostate cancer.

Dr. Gomella on Immunotherapy Developments in Prostate Cancer

March 19th 2018

Leonard Gomella, MD, professor, chair, Department of Urology, director, Sidney Kimmel Cancer Center Network, Thomas Jefferson University Hospital, discusses immunotherapy developments for patients with prostate cancer.

Dr. Mann on Immunotherapy Developments in Prostate Cancer

March 19th 2018

Mark J. Mann, MD, assistant professor, Sidney Kimmel Cancer Center, Thomas Jefferson Hospital, discusses the future of immunotherapy in prostate cancer.

Expert Makes Case for Hypofractionation in Prostate Cancer

March 19th 2018

Howard M. Sandler, MD, discusses the emergence of hypofractionation as a viable treatment approach for patients with prostate cancer.

Dr. Mason on Next Steps Following 10-Year PROTECT Study Data in Prostate Cancer

March 15th 2018

Malcolm Mason, MD, Cancer Research Wales Professor of Clinical Oncology at Cardiff University, discusses next steps following the 10-year PROTECT study data for patients with prostate cancer.

Expert Emphasizes Healthy Lifestyle in Prostate Cancer Care

March 15th 2018

Stephen J. Freedland, MD, shares his insight on how to counsel patients with prostate cancer on the benefits of leading a healthier life.

Expert Discusses Optimizing HIFU and Other Strategies in Prostate Cancer

March 14th 2018

Timothy J. Daskivich, MD, discusses the use of High-intensity focused ultrasound and other treatment strategies in the prostate cancer armamentarium.

Dr. Slovin on the Promise of GnRH Antagonists in Prostate Cancer

March 13th 2018

Susan F. Slovin, MD, PhD, a medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the promise of GnRH antagonists in prostate cancer.

Managing Advanced Prostate Cancer in the Future

March 13th 2018